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Bis(2-hydroxy-3-tert-butyl-5-methylphenyl)methane (bis-phenol) is the most potent inhibitor of the 
(Caz+ + MgZ+)-ATPase of skeletal muscle sarcoplasmic reticulum yet identified. The compound behaves as 
a reversible, tight-binding inhibitor with apparant K, =0.3 PM. Butylated hydroxytoluene, butylated hy- 
droxyanisole, and 4-nonylphenol are also effective inhibitors. These observations are of particular interest 
in light of the widespread use of such phenolic antioxidants and stabilizers in the food industry and in the 
manufacture of rubbers and plastics and the ease with which the compounds are extracted into organic sol- 
vents. 
(Ca2+ + Mg2’)-ATPase Sarcoplasmic reticulum 
1. INTRODUCTION 
The (Ca’+ + Mg’+)-ATPase of skeletal muscle 
sarcoplasmic reticulum (SR) is a single polypeptide 
chain of M, 100000, which spans the lipid bilayer. 
It catalyzes the central biochemical step in muscle 
relaxation by coupling the cleavage of ATP to the 
transport of two Ca’+ into the lumen of the SR, 
against a concentration gradient [l-4]. 
Pumiliotoxin B, an indolizidine alkaloid isolated 
from the neotropical frog Dendrobates pumilio 
[5,6], has been reported to be an inhibitor of the 
(Ca2+ +Mg’+)-ATPase of both rat and frog SR 
[7-91. Subsequent studies revealed that the inhibi- 
tion of SR (Ca’+ + Mg’+)-ATPase by pumiliotoxin 
B was due to an impurity or impurities. (Removal 
of the impurities by high-pressure liquid 
chromatography did not affect the myotonic or 
cardiotonic activities of pumiliotoxin B.) An ex- 
haustive study on the source and nature of the im- 
purities responsible for inhibition of the SR 
ATPase revealed them to be phenols, namely 
bis(2-hydroxy-3-tert-butyl-5_methylphenyl)meth- 
ane (bis-phenol), 3,5-tert-butyl-4-hydroxytoluene 
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(butylated hydroxytoluene, BHT) and 4-nonylphe- 
nols (see table 1 for structures). Because bis- 
phenol, BHT and the nonylphenols are widely 
utilized by the manufacturing sector and dispersed 
in the environment [lO,ll], their effects on the SR 
ATPase have been examined in further detail. 
2. MATERIALS AND METHODS 
2.1. Biochemical assays 
SR vesicles were prepared from the hind-limb 
musculature of male Sprague-Dawley rats [12] and 
stored frozen (-80°C) until use. The freeze- 
thawed vesicles were sufficiently leaky to Ca’+ that 
sonication failed to stimulate the ATPase. ATPase 
activity was measured spectrophotometrically by 
enzymatically coupling ADP production to the 
stoichiometric oxidation of NADH [ 131. Ca’+ con- 
centrations were calculated as described by Fabiato 
and Fabiato [14]. The program uses 5.267 x 10” 
as the absolute stability constant for the 
Ca2+-EGTA complex. This yields an apparent 
stability constant of 3.969 x lo6 (pH 7.1, ionic 
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strength 0.16, temperature 22’C). The program 
considers, in addition, equilibria involving Mg*+, 
K+, H+ and ATP. Protein was determined ac- 
cording to Lowry et al. [15]. Qualitatively similar 
results were obtained with a (Ca*+ +Mg*+)- 
ATPase solubilized and purified according to 
MacLennan [ 161. 
2.2. Identification of impurities in PTX-B samples 
Both natural and synthetic [17] samples of 
pumiliotoxin B that had been purified by silica gel 
chromatography inhibited the SR ATPase, while a 
sample purified by high-pressure liquid 
chromatography was inactive. The inhibitory im- 
purities derived both from the solvents 
(chloroform/methanol, 6 : 1; J .T. Baker, Reagent 
Grade) and from the apparatus (Chromatotron, 
Harrison Research, Palo Alto, CA) used for cen- 
trifugal thin-layer chromatography. The inhibitory 
principles were non-volatile and stable to heating 
at 150°C for 10 min. The non-volatile residue 
from the passage of 1 1 CHCls-CH3OH (6: 1) 
through the Chromatotron was chromatographed 
on LH-20 Sepharose. Inhibition of ATPase activi- 
ty was maximal in those fractions having UV ab- 
sorption at 270-280 nm and exhibiting (along with 
minor peaks) major gas chromatographic peaks 
with retention times of 13.85 and 15.30 min (25 m 
fused silica capillary, OV-1 stationary phase, 
150-300°C at lO”C/min). Combined gas 
chromatography-mass spectrometry (electron im- 
pact mode) identified these two peaks as cor- 
responding respectively to bis-phenol and a 
methanolysis photoproduct of bis-phenol. (The 
methanolysis product arises subsequent to the 
Chromatotron operation by exposure of the ex- 
tract to room daylight .) All samples of pumiliotox- 
in B purified by the Chromatotron revealed, 
superimposed on the broader peak corresponding 
to pumiliotoxin B (13.85 min), the sharper peak 
from the bis-phenol. The bis-phenol derived from 
the Delrin plastic of the Chromatotron and is 
primarily responsible for inhibition of ATPase 
observed with samples of pumiliotoxin B purified 
by the Chromatotron. The eluant also contained 
BHT (retention time 5.35 min) and 4-nonylphenols 
(retention times 7-7.8 min). These phenols could 
also be demonstrated in residues from commercial 
chloroform (J.T. Baker, Reagent Grade) and may 
arise in this case from the bottle’s plastic cap. Such 
phenols can be extracted from plastic caps and/or 
liners even when only the vapors of organic 
solvents, such as methanol, are in contact with the 
plastic. ATPase inhibition observed for samples of 
pumiliotoxin B not purified by the Chromatotron 
but by column chromatography is accounted for 
by the presence of BHT and/or 4-nonylphenols. 
3. RESULTS AND DISCUSSION 
The inhibitory effectiveness of bis-phenol 
depends on the concentration of ATPase present in 
the assay (fig. 1A). Behavior of this sort is expected 
when the concentration of enzyme in an assay (Et) 
is substantial relative to Ki, the dissociation con- 
stant for the enzyme-inhibitor complex, e.g., Et/Ki 
> 0.1 [18]. An Ackerman-Potter plot of ATPase 
IInkbitorl(pM1 [PROTEINI (pg/ml I 
Fig. 1. Inhibition of the (Ca’+ + Mg*+)-ATPase of rat 
skeletal muscle SR by bis-phenol. (A) Effect of protein 
concentration on inhibition by bis-phenol. Protein 
concentrations (inpg . ml-‘) are indicated adjacent to the 
curves. (B) Ackerman-Potter plot for bis-phenol 
inhibition of the ATPase. Bis-phenol concentrations 
kM) are indicated adjacent to the curves. Assays were 
conducted at 22°C in 0.3 ml containing 20 mM 
imidazole-HCl (pH 7.0), 100 mM KCl, 1 mM MgC12, 
0.4 mM phosphoenolpyruvate, 0.14 mM NADH, 
1OOpM EGTA, 50pM ATP, sufficient CaCl2 to yield 
Ca*+ concentration of 0.3 pM; and excess lactate 
dehydrogenase and pyruvate kinase. At these substrate 
concentrations > 96% of the detectable ATPase activity 
is Ca2+-dependent. Absorbance was followed 
continuously at 340 nm, and rates were calculated using 
an extinction coefficient of 6270 cm-’ - M-’ for NADH. 
Bis-phenol obtained from Pfaltz and Bauer (Flushing, 
NY) was added as a methanolic solution and results were 
corrected for minor effects of the solvent. The data 
obtained in the absence of inhibitor are approximated 
using the linear least-squares approach (R = 0.998); 
other lines were drawn by eye. 
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activity as a function of enzyme concentration for 
several concentrations of bis-phenol (fig. 1B) is also 
consistent with identification of the compound as 
an apparently tight-binding inhibitor [ 19,201. In 
both plots, the deviation from conventional 
Michaelis-Menten kinetics reflects the change in 
free inhibitor concentration resulting from 
inhibitor-enzyme interaction. 
Although GO (the concentration of inhibitor re- 
quired to produce 50% inhibition) depends on the 
concentration of enzyme in the assay, the apparent 
Ki does not [20]. An apparent Ki value for the in- 
hibitor of 0.29 f O.O9/cM was estimated, using 
data from three experiments of the sort shown in 
fig.lA. Ki is given by the y-intercept of a plot of 
CSO vs relative enzyme concentration [20-221. An 
apparent Ki of 0.32 + 0.08 PM (five experiments) 
was calculated using the equation 
Ki = 2(C75)/3 - COO, 
where COO and C75, the inhibitor concentration 
producing 75% inhibition, are determined for a 
single enzyme concentration [22]. SR protein con- 
centrations employed in these assays fell between 2 
and 24 pg - ml-’ , Assuming that the SR ATPase ac- 
counts for 60% of the protein in the preparation 
and assuming an A& of 100000 [l-4], an enzyme 
Table 1 
Effect of several phenolic antioxidants on the (Ca2+  Mg2+)-ATPase of rat skeletal muscle SR 
Antioxidant Structure Go 01M) 
Bis-phenol* 
4-Nonylphenolsb 
3,5-Dibutyl-4-hydroxytoluene 
(BHT)C 
C(W), 
0.70 f 0.05 (n = 6) 
1.68 (n = 2) 
4.6 f 0.7 (n = 3) 
3,5-Dibutyl-4-hydroxyanisole’ 
OH 
cWS3 12.2 (n = 2) 
o&H, 
a Pfaltz and Bauer (Flushing, NY) 
b A complex mixture of branched chain isomers. Fluka (Hauppauge, NY) 
’ Aldrich (Milwaukee, WI) 
Assay conditions were as described for fig.1, except that protein concentration was fixed at 7.05 ,ug .ml-‘. As 
demonstrated in fig.1, COO values for these compounds are not constant but vary with enzyme concentration. Values 
shown are the mean f SD of the number of determinations indicated in parentheses 
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concentration of between 0.012 and 0.125 ,uM, 
corresponding to EJKi ratios of 0.04-0.40, can be 
calculated. Greco and Hakala 1221 suggest hat the 
most precise estimations of Ki can be made in this 
range, in which appreciable dissociation of the 
enzyme-inhibitor complex occurs. 
For true tight-binding inhibitors (Ki < 1 nM), 
slowness of association-dissociation reactions 
often precludes steady-state analysis of data. This 
is not the case for inhibition of the SR 
(Ca*+ + Mg*+)-ATPase by bis-phenol. No cur- 
vature in reaction progress curves was observed. 
Furthermore, no difference in reaction course 
could be detected when the reaction was begun by 
(i) addition of enzyme or (ii) addition of 
substrate(s) (Ca*+, ATP, or Ca*+ +ATP) to en- 
zyme preincubated with inhibitor. In this enzyme 
system, behavior characteristic of a tight-binding 
inhibitor is a reflection of the Et/Ki ratio rather 
than a Ki value in the nanomolar range. An ap- 
parent Ki > 10m7 M is, in fact, compatible with 
steady-state kinetics [21]. 
CSO values for several phenolic antioxidants, 
assayed under standard conditions, are summariz- 
ed in table 1. Inhibitory potency varies over an 
order of magnitude with bis-phenol > 
4-nonylphenols > dibutylhydroxytoluene > 
dibutylhydroxyanisole. Quercetin, a flavanoid 
isolated from plant sources, has also been 
characterized as a potent, reversible inhibitor of 
the SR (Ca*+ + Mg*+)-ATPase [23-241. The CSO 
for quercetin is approx. 10 /cM. However, 
quercetin is a general inhibitor of energy conver- 
sion reactions, active at similar concentrations 
against the Fi/Fo ATPases of mitochondria [25] 
and chloroplasts [26]. Bis-phenol is, by contrast, 
without inhibitory effect on the ATPase of rat 
heart mitochondria (not shown). The phenolic an- 
tioxidant is, thus, both more potent and more 
selective than quercetin. 
The (Ca’+ +Mg*+)-ATPase of SR couples the 
vectorial movement of Ca*+ to the hydrolysis of 
ATP by means of a reaction mechanism that com- 
prises at least 8 steps [l-4], namely: (1) Two Ca2+ 
interact with the enzyme at high-affinity sites 
oriented towards the cytoplasm. (2) ATP binds to 
the catalytic site of the enzyme and (3) a covalent 
enzyme-phosphate intermediate is formed. (4) 
Ca*’ is translocated through the SR membrane 
and the affinity of the enzyme for Ca2+ decreases 
124 
such that (5) Ca*+ is released into the lumen. Final- 
ly, in a two-step process (6,7), the enzyme- 
phosphate bond is hydrolyzed, and (8) the enzyme 
returns to a conformation with high-affinity 
Ca*+-binding sites facing the cytoplasm. Two of 
these steps, 4 and 8, can be considered isomeric 
rearrangement reactions; orientations rather than 
binding interactions are altered. These steps are of 
particular interest because they require interplay 
between the enzyme and its membrane environ- 
ment and because step 4 appears to be rate-limiting 
under most circumstances. Several manipulations 
(an increase in temperature, lowered pH, and the 
presence of organic solvents such as dimethyl 
sulfoxide) shift the equilibria of these two reac- 
tions in favor of the low-affinity form of the en- 
zyme [27]. 
Preliminary characterization of the inhibitory 
interaction of bis-phenol with the (Ca*+ + Mg*+)- 
ATPase suggests that bis-phenol also acts on these 
two conformational rearrangement steps. In- 
hibitory effectiveness increases with increasing 
assay temperature, i.e. bis-phenol decreases the ab- 
solute value of the slope of an Arrhenius plot for 
the ATPase reaction (fig.2A). Inhibition is an- 
tagonized by concentrations of the non-ionic 
detergent Triton X-100 well below the critical 
micelle concentration [28] particularly at higher 
temperatures (fig.2A). Inhibition is enhanced as 
the assay pH is lowered. For example, a decrease 
in assay pH from 8.1 to 6.6 increased the inhibition 
obtained with 0.56rM bis-phenol from 17.8 to 
56.6% (assay conditions as in fig.1; protein con- 
centration 7.05 pgeml-‘). Inhibition of the 
(Ca*+ + Mg’+)-ATPase by bis-phenol is non- 
competitive with respect to Ca2+ (fig.2B,C), but 
“the complexity of tight-binding inhibition equa- 
tions mitigate against their use for determination 
of values of kinetic parameters” [20]. The interac- 
tions of Ca’+, bis-phenol, and the ATPase are 
strongly influenced by temperature (cf. fig.ZB and 
C). At lower temperature an increase in Ca*+ con- 
centration decreases ATPase activity. Presumably 
Ca*+ interacts with the low-affinity form of the 
Ca2+-binding site and inhibits step 4. Under these 
conditions, bis-phenol enhances enzyme activity. 
The dependence of inhibition on ATP concentra- 
tion is influenced by Ca*+ concentration: at 
0.3 pM Ca2+ bis-phenol inhibition is non- 
competitive with respect to ATP (fig.2D). At a 
Volume 203, number 2 FEBS LETTERS July 1986 
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Fig.2. Characterization of bis-phenol inhibition of the SR (Ca’+ + Mg’+)-ATPase. Assay conditions were as outlined 
in fig. 1, except that protein concentration was held constant at 7.05 pg. ml-‘. (A) Effect of temperature and of Triton 
X-100. The data shown were obtained in the absence of further additions (0), in the presence of 0.56 PM bis-phenol 
(0) and in the presence of both 0.56pM bis-phenol and 0.005% Triton X-100 (A). When the assay mixture was 
supplemented with 0.005% Triton only, a curve similar to that shown for Triton plus bis-phenol, but slightly steeper, 
resulted. Measured rates ran from 0.407 ~mol.min-‘eng-’ at 13.5’C to 5.69pmol.min-‘-mg-’ at 34.5”C. Arrhenius 
plots, all of which had IR I > 0.996 for the temperature range 13.5-29.5”C, had slopes of - 3.89 (control), - 2.96 (bis- 
phenol), - 4.56 (Triton plus bis-phenol) and - 5.58 (Triton). (B,C) Dependence on Ca2+ concentration (B, 22°C; C, 
34.5”C). The data shown are for controls (O), and for assays in the presence of 0.23 /IM (B), 0.56 PM (0) and 1.12 pM 
(A) bis-phenol. (D,E) Lineweaver-Burk plots for the effect of ATP (D, 0.3 ,uM Ca2+; E, 1.2 pM Ca’+). Symbols as in 
panels B and C. The concave downward curves in E are characteristic both of the ATP dependence of the enzyme and 
of Lineweaver-Burk plots for tight-binding inhibitors. 
higher Ca*+ concentration (1.2 FM), Lineweaver- 
Burk plots suggest competitive interactions be- 
tween ATP and bis-phenol (fig.2E). 
In summary, factors that are believed to shift the 
equilibria of steps 4 and 8 toward the low-affinity 
forms of the enzyme (increased temperature, low 
pH) enhance inhibition by bis-phenol; elevated 
Ca2+ concentrations, which decrease the flux 
through step 4, create a situation in which low con- 
centrations of bis-phenol are stimulatory. Finally, 
the detergent Triton X-100, which might be ex- 
pected to influence primarily enzyme conforma- 
tion alterations occurring within the SR mem- 
brane, overcomes bis-phenol inhibition. These fin- 
dings suggest that bis-phenol and related com- 
pounds act on the crucial steps in the ATPase reac- 
tion cycle during which reorientation of the 
Ca*+-binding sites and ion translocation occur. 
Bis-phenol has also been shown to inhibit Ca*+ up- 
take into SR vesicles, measured in the presence of 
125 
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inorganic phosphate to keep the ionized Ca2+ con- 
centration low. Inhibition is dependent on protein 
concentration, and inhibitor potency is similar to 
that observed for the uncoupled ATPase reaction 
(Beeler, T.H., personal communication). The 
phenolic antioxidants will therefore be valuable 
tools for probing and manipulating the complex 
reaction sequence of the ATPase and the ion 
translocation steps in particular. 
Because phenolic antioxidants or stabilizers are 
common, unregulated additives employed in a 
broad spectrum of industries, their severe effects 
on the activity of a key enzyme in muscle 
physiology are of clear, general concern. The 
agents utilized in this study were identified initially 
as contaminants of an alkaloid purified by stan- 
dard chromatographic procedures [5,6]. They were 
found to originate from the Delrin plastic of the 
chromatographic apparatus and to be present in 
commercial chloroform. Similarly, incubation of 
disposable pipet tips in methanol at 4°C for 1 h 
elutes compounds capable of inhibiting the 
ATPase, as does extended contact of caps of vials, 
tubes and bottles with vapors from methanol. The 
ease with which such inhibitory compounds are ex- 
tracted by organic solvents from some plastic 
laboratory ware and caps of glassware should be 
recognized by research scientists. 
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